Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  HIV Infection

  Free Subscription


01.01.2024

2 AIDS
1 BMJ
1 Clin Infect Dis
2 HIV Med
9 J Acquir Immune Defic Syndr
3 J Infect Dis
2 J Med Virol
2 Lancet Infect Dis
5 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. THORNHILL JP, Fox J, Martin GE, Hall R, et al
    Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recovery.
    AIDS. 2023 Dec 21. doi: 10.1097/QAD.0000000000003825.
    PubMed         Abstract available

  2. KEBEDE S, Brazier E, Freeman AM, Muwonge TR, et al
    PrEP Availability Among Health Facilities Participating in the Global IeDEA Consortium.
    AIDS. 2023 Dec 22. doi: 10.1097/QAD.0000000000003824.
    PubMed         Abstract available


    BMJ

  3. RAHANGDALE L, Teodoro N, Chinula L, Brewer NT, et al
    Eliminating cervical cancer as a global public health problem requires equitable action.
    BMJ. 2023;383:2978.
    PubMed        


    Clin Infect Dis

  4. KOSANA P, Wu K, Tassiopoulos K, Letendre S, et al
    Polypharmacy is associated with slow gait speed and recurrent falls in older people with HIV.
    Clin Infect Dis. 2023 Dec 26:ciad782. doi: 10.1093.
    PubMed         Abstract available


    HIV Med

  5. OKA S, Holohan V, Shirasaka T, Choi JY, et al
    Asian participants' experience in phase 3/3b studies of long-acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96.
    HIV Med. 2023 Dec 26. doi: 10.1111/hiv.13588.
    PubMed         Abstract available

  6. ESSER S, Brunetta J, Inciarte A, Levy I, et al
    Twelve-month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real-world insights from BICSTaR cohorts.
    HIV Med. 2023 Dec 26. doi: 10.1111/hiv.13593.
    PubMed         Abstract available


    J Acquir Immune Defic Syndr

  7. JONES R, Jessee MB, Booker R, Martin SL, et al
    Associations between Estimates of Arterial Stiffness and Cognitive Functioning in Adults with HIV.
    J Acquir Immune Defic Syndr. 2023 Dec 22. doi: 10.1097/QAI.0000000000003374.
    PubMed         Abstract available

  8. NYANDIKO W, Enjema NA, Mugo R, Apondi E, et al
    PREDICTORS OF MORTALITY AMONG CHILDREN AND ADOLESCENTS LIVING WITH HIV ON ANTIRETROVIRAL THERAPY IN WESTERN KENYA.
    J Acquir Immune Defic Syndr. 2023 Dec 15. doi: 10.1097/QAI.0000000000003361.
    PubMed         Abstract available

  9. RILEY ED, Vittinghoff E, Ravi A, Coffin PO, et al
    The role of substance use in structural heart disease among women living with HIV.
    J Acquir Immune Defic Syndr. 2023 Dec 19. doi: 10.1097/QAI.0000000000003366.
    PubMed         Abstract available

  10. KEDDEM S, Thatipelli S, Caceres O, Roder N, et al
    Barriers and Facilitators to Long-Acting Injectable HIV PrEP Implementation in Primary Care Since Its Approval in the United States.
    J Acquir Immune Defic Syndr. 2023 Dec 22. doi: 10.1097/QAI.0000000000003370.
    PubMed         Abstract available

  11. THOMAS D, Nakabugo L, Nambi F, Kibuuka J, et al
    Intimate partner violence and adherence to PrEP and ART among Ugandan HIV serodifferent couples.
    J Acquir Immune Defic Syndr. 2023 Dec 19. doi: 10.1097/QAI.0000000000003368.
    PubMed         Abstract available

  12. KIM TW, Bertholet N, Magane KM, Lloyd-Travaglini C, et al
    Alcohol consumption and illicit drug use: associations with fall, fracture, and acute healthcare utilization among people with HIV infection.
    J Acquir Immune Defic Syndr. 2023 Dec 22. doi: 10.1097/QAI.0000000000003372.
    PubMed         Abstract available

  13. RAMAKRISHNAN A, Fujita AW, Mehta CC, Wilson TE, et al
    Substance Use Care Continuum in Women with and without HIV in the Southern United States.
    J Acquir Immune Defic Syndr. 2023 Dec 22. doi: 10.1097/QAI.0000000000003373.
    PubMed        

  14. RAMIREZ-ORTIZ D, Jean-Gilles M, Sheehan DM, Ladner R, et al
    Factors Associated with COVID-19 Vaccination among Racial/Ethnic Minority Groups with HIV in South Florida.
    J Acquir Immune Defic Syndr. 2023 Dec 22. doi: 10.1097/QAI.0000000000003369.
    PubMed         Abstract available

  15. BYRD KK, Buchacz K, Crim SM, Beer L, et al
    Unmet needs for HIV ancillary services among persons with diagnosed HIV aged 55 years and older.
    J Acquir Immune Defic Syndr. 2023 Dec 22. doi: 10.1097/QAI.0000000000003365.
    PubMed         Abstract available


    J Infect Dis

  16. LUCERO-OBUSAN C, Oda G, Schirmer P, Edson C, et al
    Epidemiology of the 2022 Mpox Outbreak in the US Veterans Health Administration.
    J Infect Dis. 2023 Dec 22:jiad600. doi: 10.1093.
    PubMed         Abstract available

  17. ELLIOT E, Polli JW, Patel P, Garside L, et al
    Efficacy, safety, and pharmacokinetics by BMI category in Phase 3/3b cabotegravir + rilpivirine long-acting trials.
    J Infect Dis. 2023 Dec 22:jiad580. doi: 10.1093.
    PubMed         Abstract available

  18. MAKAROVA N, Singletary T, Peet MM, Mitchell J, et al
    Extended post-exposure protection against vaginal SHIV infection with tenofovir alafenamide fumarate/elvitegravir inserts in macaques.
    J Infect Dis. 2023 Dec 22:jiad599. doi: 10.1093.
    PubMed         Abstract available


    J Med Virol

  19. SISTERE-ORO M, Du J, Wortmann DDJ, Filippi MD, et al
    Pan-pox-specific T-cell responses in HIV-1-infected individuals after JYNNEOS vaccination.
    J Med Virol. 2024;96:e29317.
    PubMed         Abstract available

  20. LI J, Nie L, Guo C, Deng Y, et al
    Immunogenicity and safety of inactivated SARS-CoV-2 vaccines in people living with HIV: A longitudinal cohort study.
    J Med Virol. 2023;95:e29334.
    PubMed         Abstract available


    Lancet Infect Dis

  21. SAMARASEKERA U
    New guidance on infections in people who inject drugs.
    Lancet Infect Dis. 2024;24:e19.
    PubMed        

  22. SCHILLING WHK, Jittamala P, Watson JA, Boyd S, et al
    Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial.
    Lancet Infect Dis. 2023 Sep 28:S1473-3099(23)00493.
    PubMed         Abstract available


    PLoS One

  23. BLAYLOCK JM, Ewers EC, Bianchi EJ, King DB, et al
    Risk of sexually transmitted infections among U.S. military service members in the setting of HIV pre-exposure prophylaxis use.
    PLoS One. 2023;18:e0296054.
    PubMed         Abstract available

  24. JERE J, Ruark A, Bidwell JT, Butterfield RM, et al
    "High blood pressure comes from thinking too much": Understandings of illness among couples living with cardiometabolic disorders and HIV in Malawi.
    PLoS One. 2023;18:e0296473.
    PubMed         Abstract available

  25. AVENANT C, Bick AJ, Skosana SB, Dlamini S, et al
    Misreporting contraceptive use and the association of peak study progestin levels with weight and BMI among women randomized to the progestin-only injectable contraceptives DMPA-IM and NET-EN.
    PLoS One. 2023;18:e0295959.
    PubMed         Abstract available

  26. STONER MCD, Ming K, Wagner D, Smith L, et al
    Youth Ending the HIV Epidemic (YEHE): Protocol for a pilot of an automated directly observed therapy intervention with conditional economic incentives among young adults with HIV.
    PLoS One. 2023;18:e0289919.
    PubMed         Abstract available

  27. GILS T, Kamele M, Madonsela T, Bosman S, et al
    Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation.
    PLoS One. 2023;18:e0296197.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.